{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:41:12Z","timestamp":1772934072398,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85807-4","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T07:22:25Z","timestamp":1736320945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiafei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aili","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"85807_CR1","doi-asserted-by":"crossref","unstructured":"Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157, 107843. (2019).","DOI":"10.1016\/j.diabres.2019.107843"},{"issue":"6","key":"85807_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","volume":"61","author":"RCW Ma","year":"2018","unstructured":"Ma, R. C. W. Epidemiology of diabetes and diabetic complications in China. Diabetologia 61 (6), 1249\u20131260 (2018).","journal-title":"Diabetologia"},{"issue":"7","key":"85807_CR3","first-page":"RA130","volume":"12","author":"BK Tripathi","year":"2006","unstructured":"Tripathi, B. K. & Srivastava, A. K. Diabetes mellitus: complications and therapeutics. Med. Sci. Monit. 12 (7), RA130\u2013RA147 (2006).","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"85807_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.autrev.2011.09.003","volume":"11","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y., Jiang, Z. & Guo, C. New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells. Autoimmun. rev. 11 (2), 137\u2013142 (2011).","journal-title":"Autoimmun. rev."},{"key":"85807_CR5","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"85807_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/1471-2458-12-567","volume":"12","author":"P-H Zhang","year":"2012","unstructured":"Zhang, P-H. et al. Zhu Y-M: increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health. 12, 567 (2012).","journal-title":"BMC Public. Health"},{"key":"85807_CR7","doi-asserted-by":"publisher","first-page":"46527","DOI":"10.1038\/srep46527","volume":"7","author":"S de Kort","year":"2017","unstructured":"de Kort, S. et al. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation. Sci. Rep. 7, 46527 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"85807_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13813450801954451","volume":"114","author":"P Pisani","year":"2008","unstructured":"Pisani, P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch. Physiol. Biochem. 114 (1), 63\u201370 (2008).","journal-title":"Arch. Physiol. Biochem."},{"issue":"5","key":"85807_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"DK Andersen","year":"2017","unstructured":"Andersen, D. K. et al. Diabetes, pancreatogenic diabetes, and pancreatic Cancer. Diabetes 66 (5), 1103\u20131110 (2017).","journal-title":"Diabetes"},{"issue":"4","key":"85807_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala, R. et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134 (4), 981\u2013987 (2008).","journal-title":"Gastroenterology"},{"key":"85807_CR11","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. A. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350, g7607 (2015).","journal-title":"BMJ"},{"issue":"12","key":"85807_CR12","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1373\/clinchem.2008.105601","volume":"54","author":"CM Sturgeon","year":"2008","unstructured":"Sturgeon, C. M. et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin. Chem. 54 (12), e11\u2013e79 (2008).","journal-title":"Clin. Chem."},{"issue":"33","key":"85807_CR13","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","volume":"24","author":"GY Locker","year":"2006","unstructured":"Locker, G. Y. et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24 (33), 5313\u20135327 (2006).","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"85807_CR14","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s41416-020-01254-0","volume":"124","author":"AM Starzer","year":"2021","unstructured":"Starzer, A. M. et al. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. Br. J. Cancer. 124 (7), 1294\u20131300 (2021).","journal-title":"Br. J. Cancer"},{"key":"85807_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psychres.2018.11.043","volume":"271","author":"S \u00d6zdin","year":"2019","unstructured":"\u00d6zdin, S. & B\u00f6ke, \u00d6. Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in different stages of schizophrenia. Psychiatry Res. 271, 131\u2013135 (2019).","journal-title":"Psychiatry Res."},{"key":"85807_CR16","doi-asserted-by":"publisher","first-page":"102910","DOI":"10.1016\/j.redox.2023.102910","volume":"67","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. Associations of essential trace elements with epigenetic aging indicators and the potential mediating role of inflammation. Redox Biol. 67, 102910 (2023).","journal-title":"Redox Biol."},{"issue":"8","key":"85807_CR17","doi-asserted-by":"publisher","first-page":"e2331197","DOI":"10.1001\/jamanetworkopen.2023.31197","volume":"6","author":"LNC Boyd","year":"2023","unstructured":"Boyd, L. N. C. et al. Prediction model for early-stage pancreatic Cancer using routinely measured blood biomarkers. JAMA Netw. Open. 6 (8), e2331197 (2023).","journal-title":"JAMA Netw. Open."},{"key":"85807_CR18","doi-asserted-by":"crossref","unstructured":"Zhu, X. et al. Pancreatic Cancer: an exocrine tumor with endocrine characteristics. Ann. Surg. (2023).","DOI":"10.1097\/SLA.0000000000006168"},{"key":"85807_CR19","unstructured":"Tempero, M. A. et al. Pancreatic adenocarcinoma. J. Natl. Compr. Canc Netw. 8(9). (2010)."},{"key":"85807_CR20","doi-asserted-by":"publisher","first-page":"103779","DOI":"10.1016\/j.critrevonc.2022.103779","volume":"178","author":"D-W Kang","year":"2022","unstructured":"Kang, D-W., Barnes, O., Vander Heiden, M. G. & Dieli-Conwright, C. M. Effect of exercise on tumor markers - is exercise anti-tumorigenic in humans? A scoping review of preliminary clinical investigations. Crit. Rev. Oncol. Hematol. 178, 103779 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"85807_CR21","doi-asserted-by":"crossref","unstructured":"Lega, I. C. & Lipscombe, L. L. Review: diabetes, obesity, and Cancer-Pathophysiology and Clinical implications. Endocr. Rev. 41(1). (2020).","DOI":"10.1210\/endrev\/bnz014"},{"issue":"4","key":"85807_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4239\/wjd.v15.i4.645","volume":"15","author":"T-Z Fang","year":"2024","unstructured":"Fang, T-Z. et al. Influence of blood glucose fluctuations on chemotherapy efficacy and safety in type 2 diabetes mellitus patients complicated with lung carcinoma. World J. Diabetes. 15 (4), 645\u2013653 (2024).","journal-title":"World J. Diabetes"},{"issue":"6","key":"85807_CR23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.7150\/jca.91758","volume":"15","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. Age-related disparities in Pan-cancer Mortality and causes of death: analysis of Surveillance, Epidemiology, and end results (SEER) data. J. Cancer. 15 (6), 1613\u20131623 (2024).","journal-title":"J. Cancer"},{"issue":"2","key":"85807_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.15537\/smj.2017.2.15649","volume":"38","author":"X Shang","year":"2017","unstructured":"Shang, X. et al. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control. Saudi Med. J. 38 (2), 204\u2013208 (2017).","journal-title":"Saudi Med. J."},{"issue":"2","key":"85807_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12020-022-03100-0","volume":"77","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms. Endocrine 77 (2), 262\u2013271 (2022).","journal-title":"Endocrine"},{"issue":"Suppl 2","key":"85807_CR26","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.2337\/dc08-s243","volume":"31","author":"MY Donath","year":"2008","unstructured":"Donath, M. Y. et al. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care. 31 (2), S161\u2013S164 (2008).","journal-title":"Diabetes Care"},{"key":"85807_CR27","doi-asserted-by":"publisher","first-page":"745189","DOI":"10.1155\/2012\/745189","volume":"2012","author":"H Yu","year":"2012","unstructured":"Yu, H. et al. Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients. Exp. Diabetes Res. 2012, 745189 (2012).","journal-title":"Exp. Diabetes Res."},{"issue":"3","key":"85807_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2337\/db19-0138","volume":"69","author":"GC Weir","year":"2020","unstructured":"Weir, G. C. Glucolipotoxicity, \u03b2-Cells, and diabetes: the Emperor has no clothes. Diabetes 69 (3), 273\u2013278 (2020).","journal-title":"Diabetes"},{"issue":"5","key":"85807_CR29","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","volume":"432","author":"M Lytrivi","year":"2020","unstructured":"Lytrivi, M., Castell, A-L., Poitout, V. & Cnop, M. Recent insights into mechanisms of \u03b2-Cell lipo- and glucolipotoxicity in type 2 diabetes. J. Mol. Biol. 432 (5), 1514\u20131534 (2020).","journal-title":"J. Mol. Biol."},{"issue":"4","key":"85807_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.dld.2015.12.006","volume":"48","author":"SH Lee","year":"2016","unstructured":"Lee, S. H. et al. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2. Dig. Liver Dis. 48 (4), 435\u2013440 (2016).","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"85807_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/0300891620976945","volume":"107","author":"A Pretta","year":"2021","unstructured":"Pretta, A. et al. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus. Tumori 107 (6), 550\u2013555 (2021).","journal-title":"Tumori"},{"key":"85807_CR32","doi-asserted-by":"publisher","first-page":"608966","DOI":"10.3389\/fendo.2020.608966","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu, S., Wang, J., Jing, L. & Chen, L. A Diabetic Patient Complicated with Pancreatic Cancer after using Liraglutide: a Case Report. Front. Endocrinol. 11, 608966 (2020).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"85807_CR33","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.1038\/s41598-024-60867-0","volume":"14","author":"R Xu","year":"2024","unstructured":"Xu, R. et al. Exploration of the application potential of serum multi-biomarker model in colorectal cancer screening. Sci. Rep. 14 (1), 10127 (2024).","journal-title":"Sci. Rep."},{"issue":"5","key":"85807_CR34","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1002\/tox.24152","volume":"39","author":"X Wang","year":"2024","unstructured":"Wang, X., Gao, Y., Wang, H., Gong, X. & Bao, P. Tumor markers for lipid metabolism-related genes: based on small cell lung cancer and bronchial asthma dual analysis. Environ. Toxicol. 39 (5), 2855\u20132868 (2024).","journal-title":"Environ. Toxicol."},{"issue":"1","key":"85807_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/biol-2020-0030","volume":"15","author":"J Guo","year":"2020","unstructured":"Guo, J., Wang, B., Hou, W. & Ma, K. Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus. Open. Life Sci. 15 (1), 267\u2013273 (2020).","journal-title":"Open. Life Sci."},{"issue":"10","key":"85807_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer. 21 (10), 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"85807_CR37","doi-asserted-by":"crossref","unstructured":"Yang, S. et al. Cholesterol metabolism and urinary system tumors. Biomedicines 12(8). (2024).","DOI":"10.3390\/biomedicines12081832"},{"issue":"2","key":"85807_CR38","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/ERC-12-0219","volume":"20","author":"LC Moeller","year":"2013","unstructured":"Moeller, L. C. & F\u00fchrer, D. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr. Relat. Cancer. 20 (2), R19\u2013R29 (2013).","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"85807_CR39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4239\/wjd.v15.i2.232","volume":"15","author":"M Meng","year":"2024","unstructured":"Meng, M. & Shi, L-L. Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus. World J. Diabetes. 15 (2), 232\u2013239 (2024).","journal-title":"World J. Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85807-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:02:07Z","timestamp":1736366527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85807-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85807"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85807-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was drawn up prior to the start of this study, and all subjects participating in this study signed a written informed consent form to indicate their agreement to the publication of all images, clinical data, and other data contained in the article. This study was approved by the Medical Ethics Committee of Zhejiang Xiaoshan Hospital on January 25, 2024 (NO. 2024005).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"1264"}}